Published ahead of print on May 13, 2005, doi:10.1164/rccm.200501-034OC
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 334-343, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200501-034OC
5-Lipoxygenase Deficiency Prevents Respiratory Failure during Ventilator-induced Lung Injury
Pietro Caironi,
Fumito Ichinose,
Rong Liu,
Rosemary C. Jones,
Kenneth D. Bloch and
Warren M. Zapol
Department of Anesthesia and Critical Care, and the Cardiovascular Research Center of the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Correspondence and requests for reprints should be addressed to Warren M. Zapol, M.D., Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114. E-mail: wzapol{at}partners.org
Rationale: Mechanical ventilation with high VT (HVT) progressively leads to lung injury and decreased efficiency of gas exchange. Hypoxic pulmonary vasoconstriction (HPV) directs blood flow to well-ventilated lung regions, preserving systemic oxygenation during pulmonary injury. Recent experimental studies have revealed an important role for leukotriene (LT) biosynthesis by 5-lipoxygenase (5LO) in the impairment of HPV by endotoxin. Objectives: To investigate whether or not impairment of HPV contributes to the hypoxemia associated with HVT and to evaluate the role of LTs in ventilator-induced lung injury. Methods: We studied wild-type and 5LO-deficient mice ventilated for up to 10 hours with low VT (LVT) or HVT. Results: In wild-type mice, HVT, but not LVT, increased pulmonary vascular permeability and edema formation, impaired systemic oxygenation, and reduced survival. HPV, as reflected by the increase in left pulmonary vascular resistance induced by left mainstem bronchus occlusion, was markedly impaired in animals ventilated with HVT. HVT ventilation increased bronchoalveolar lavage levels of LTs and neutrophils. In 5LO-deficient mice, the HVT-induced increase of pulmonary vascular permeability and worsening of respiratory mechanics were markedly attenuated, systemic oxygenation was preserved, and survival increased. Moreover, in 5LO-deficient mice, HVT ventilation did not impair the ability of left mainstem bronchus occlusion to increase left pulmonary vascular resistance. Administration of MK886, a 5LO-activity inhibitor, or MK571, a selective cysteinyl-LT1 receptor antagonist, largely prevented ventilator-induced lung injury. Conclusions: These results indicate that LTs play a central role in the lung injury and impaired oxygenation induced by HVT ventilation.
Key Words: hypoxic pulmonary vasoconstriction leukotrienes ventilator-induced lung injury
This article has been cited by other articles:

|
 |

|
 |
 
A. Zarbock, M. R. DiStasi, E. Smith, J. M. Sanders, G. Kronke, B. L. Harry, S. von Vietinghoff, K. Buscher, J. L. Nadler, and K. Ley
Improved Survival and Reduced Vascular Permeability by Eliminating or Blocking 12/15-Lipoxygenase in Mouse Models of Acute Lung Injury (ALI)
J. Immunol.,
October 1, 2009;
183(7):
4715 - 4722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Carvalho, P. M. Spieth, P. Pelosi, A. Beda, A. J. Lopes, B. Neykova, A. R. Heller, T. Koch, and M. Gama de Abreu
Pressure Support Ventilation and Biphasic Positive Airway Pressure Improve Oxygenation by Redistribution of Pulmonary Blood Flow
Anesth. Analg.,
September 1, 2009;
109(3):
856 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyahara, K. Hamanaka, D. S. Weber, M. Anghelescu, J. R. Frost, J. A. King, and J. C. Parker
Cytosolic phospholipase A2 and arachidonic acid metabolites modulate ventilator-induced permeability increases in isolated mouse lungs
J Appl Physiol,
February 1, 2008;
104(2):
354 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Liu, Y. Hotta, A. R. Graveline, O. V. Evgenov, E. S. Buys, K. D. Bloch, F. Ichinose, and W. M. Zapol
Congenital NOS2 deficiency prevents impairment of hypoxic pulmonary vasoconstriction in murine ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1300 - L1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med.,
April 15, 2006;
173(8):
833 - 841.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Frank and M. A. Matthay
Leukotrienes in Acute Lung Injury: A Potential Therapeutic Target?
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
261 - 262.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|